Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Multi-parametric MRI as a composite biomarker for NASH and NASH with fibrosis
Author:
McKay, A, Dennis, A, Kelly, M, Fallowfiled, J, Hirschfield,G, Neubauer, S, Banerjee, R
Journal:
Hepatology
Publication Year:
2018
Volume/Issue:
Volume 68, Issue 1
Pages:
954 Abstract 1677
Multi-parametric MRI imaging in a heterogeneous liver disease: cross-sectional evaluation of a cohort of patients with PSC
Author:
Arndtz K, Hodson J, Eddowes P, Kelly M, Dennis A, Fiore M, Green D, Banerjee R, Neubauer S, Hirschfield GM
Journal:
Hepatology
Publication Year:
2018
Volume/Issue:
Volume 68, Issue 1
Pages:
1090 Abstract 1917
Cross-sectional, prospective, evaluation of the utility of Multi-parametric MRI imaging in predicting clinically meaningful outcomes in autoimmune hepatitis
Author:
Arndtz K, Hodson J, Eddowes P, Kelly MD, Dennis A, Fiore M, Banerjee R, Neubauer S, Hirschfield GM
Journal:
AASLD ABSTRACTS (Poster)
Publication Year:
2018
Volume/Issue:
Volume 68, Issue 1
Pages:
Volume 68, Issue 1
Multiparametric magnetic resonance imaging for early detection of diffuse liver disease
Author:
Breen, D.
Journal:
Biomarkers in Medicine
Publication Year:
2018
Volume/Issue:
12(2)
Pages:
105–106
1
...
13 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD